These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 18299317

  • 1. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA.
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [Abstract] [Full Text] [Related]

  • 2. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L, He Q, Garland A, Yi Z, Aybar LT, Kepler TB, Frelinger JA, Wang B, Tisch R.
    J Immunol; 2009 Dec 01; 183(11):7585-91. PubMed ID: 19917704
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
    Wilson SS, DeLuca D.
    J Autoimmun; 1997 Oct 01; 10(5):461-72. PubMed ID: 9376074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW.
    Diabetologia; 2002 May 01; 45(5):668-76. PubMed ID: 12107747
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Administering glutamic acid decarboxylase to NOD mice prevents diabetes.
    Tisch R, Yang XD, Liblau RS, McDevitt HO.
    J Autoimmun; 1994 Dec 01; 7(6):845-50. PubMed ID: 7888040
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH.
    J Immunol; 1996 Aug 01; 157(3):1279-87. PubMed ID: 8757636
    [Abstract] [Full Text] [Related]

  • 18. Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice.
    Martinic MM, Juedes AE, Bresson D, Homann D, Skak K, Huber C, Ling E, Ejrnaes M, Wolfe T, Togher L, Christen U, von Herrath MG.
    Diabetes; 2007 Apr 01; 56(4):1059-68. PubMed ID: 17395746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.
    Vukkadapu SS, Belli JM, Ishii K, Jegga AG, Hutton JJ, Aronow BJ, Katz JD.
    Physiol Genomics; 2005 Apr 14; 21(2):201-11. PubMed ID: 15671250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.